Recent Research on Gastrointestinal Carcinoma

by Giulia Rovesti, Giorgia Marisi, Andrea Casadei-Gardini
Published 2021-01-01

Oxidative Molecular Mechanisms Underlying Liver Diseases: From Systems Biology to the Personalized Medicine

by Daniele Vergara, Andrea Casadei-Gardini, Anna M. Giudetti
Published 2019-01-01

BRCA in Gastrointestinal Cancers: Current Treatments and Future Perspectives

by Eleonora Molinaro, Kalliopi Andrikou, Andrea Casadei-Gardini, Giulia Rovesti
Published 2020-11-01

Defining the Ideal Patient with Hepatocellular Carcinoma for Second-Line Treatment

by Giandomenico Roviello, Andrea Casadei-Gardini, Stefania Nobili, Enrico Mini, Sara Fancelli
Published 2020-01-01

Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma: Preliminary Toxicity and Activity Data in Dogs

by Laura Marconato, Silvia Sabattini, Giorgia Marisi, Federica Rossi, Vito Ferdinando Leone, Andrea Casadei-Gardini
Published 2020-05-01

The Perceived Ability of Gastroenterologists, Hepatologists and Surgeons Can Bias Medical Decision Making

by Alessandro Cucchetti, Dylan Evans, Andrea Casadei-Gardini, Fabio Piscaglia, Lorenzo Maroni, Federica Odaldi, Giorgio Ercolani
Published 2020-02-01

Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes

by Francesca Ratti, Andrea Casadei-Gardini, Federica Cipriani, Guido Fiorentini, Federica Pedica, Valentina Burgio, Stefano Cascinu, Luca Aldrighetti
Published 2021-06-01

Aberrant Metabolism in Hepatocellular Carcinoma Provides Diagnostic and Therapeutic Opportunities

by Serena De Matteis, Andrea Ragusa, Giorgia Marisi, Stefania De Domenico, Andrea Casadei Gardini, Massimiliano Bonafè, Anna Maria Giudetti
Published 2018-01-01

BRAF-Mutated Colorectal Cancer: Clinical and Molecular Insights

by Francesco Caputo, Chiara Santini, Camilla Bardasi, Krisida Cerma, Andrea Casadei-Gardini, Andrea Spallanzani, Kalliopi Andrikou, Stefano Cascinu, Fabio Gelsomino
Published 2019-10-01

Epigenetic Mechanisms in Gastric Cancer: Potential New Therapeutic Opportunities

by Matteo Canale, Andrea Casadei-Gardini, Paola Ulivi, Maria Arechederra, Carmen Berasain, Pier-Luigi Lollini, Maite G. Fernández-Barrena, Matías A. Avila
Published 2020-07-01

mTOR Pathway Expression as Potential Predictive Biomarker in Patients with Advanced Neuroendocrine Tumors Treated with Everolimus

by Fabio Gelsomino, Andrea Casadei-Gardini, Francesco Caputo, Giulio Rossi, Federica Bertolini, Tiziana Petrachi, Andrea Spallanzani, Elisa Pettorelli, Shaniko Kaleci, Gabriele Luppi
Published 2020-05-01

Equivalent Efficacy but Different Safety Profiles of Gemcitabine Plus Nab-Paclitaxel and FOLFIRINOX in Metastatic Pancreatic Cancer

by Ilario Giovanni Rapposelli, Andrea Casadei-Gardini, Caterina Vivaldi, Giulia Bartolini, Laura Bernardini, Alessandro Passardi, Giovanni Luca Frassineti, Valentina Massa, Alessandro Cucchetti
Published 2021-05-01

Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib

by Oronzo Brunetti, Antonio Gnoni, Antonella Licchetta, Vito Longo, Angela Calabrese, Antonella Argentiero, Sabina Delcuratolo, Antonio Giovanni Solimando, Andrea Casadei-Gardini, Nicola Silvestris
Published 2019-10-01

Lactate Dehydrogenase in Hepatocellular Carcinoma: Something Old, Something New

by Luca Faloppi, Maristella Bianconi, Riccardo Memeo, Andrea Casadei Gardini, Riccardo Giampieri, Alessandro Bittoni, Kalliopi Andrikou, Michela Del Prete, Stefano Cascinu, Mario Scartozzi
Published 2016-01-01

EGFR, HER-2 and KRAS in canine gastric epithelial tumors: a potential human model?

by Rossella Terragni, Andrea Casadei Gardini, Silvia Sabattini, Giuliano Bettini, Dino Amadori, Chiara Talamonti, Massimo Vignoli, Laura Capelli, Jimmy H Saunders, Marianna Ricci, Paola Ulivi
Published 2014-01-01

Circulating VEGF and eNOS variations as predictors of outcome in metastatic colorectal cancer patients receiving bevacizumab

by Giorgia Marisi, Emanuela Scarpi, Alessandro Passardi, Oriana Nanni, Angela Ragazzini, Martina Valgiusti, Andrea Casadei Gardini, Luca Maria Neri, Giovanni Luca Frassineti, Dino Amadori, Paola Ulivi
Published 2017-05-01

Cytoreduction plus hyperthermic intraperitoneal chemotherapy for peritoneal carcinomatosis in colorectal cancer patients: a single-center cohort study

by Leonardo Solaini, Fabrizio D’Acapito, Alessandro Passardi, Massimo Framarini, Francesca Tauceri, Daniela Di Pietrantonio, Giovanni Luca Frassineti, Andrea Casadei Gardini, Alessandro Cucchetti, Davide Cavaliere, Giorgio Ercolani
Published 2019-03-01

Prognostic role of a new index (multi inflammatory index) in patients with metastatic colorectal cancer: results from the randomized ITACa trial

by Andrea Casadei Gardini, Emanuela Scarpi, Martina Valgiusti, Manlio Monti, Silvia Ruscelli, Laura Matteucci, Giulia Bartolini, Bernadette Vertogen, Flavia Pagan, Giulia Rovesti, Giovanni Luca Frassineti, Alessandro Passardi
Published 2020-09-01

KRAS, BRAF and PIK3CA status in squamous cell anal carcinoma (SCAC).

by Andrea Casadei Gardini, Laura Capelli, Paola Ulivi, Massimo Giannini, Eva Freier, Stefano Tamberi, Emanuela Scarpi, Alassandro Passardi, Wainer Zoli, Angela Ragazzini, Dino Amadori, Giovanni Luca Frassineti
Published 2014-01-01

Heterogeneity of Response and Immune System Activity during Treatment with Nivolumab in Hepatocellular Carcinoma: Results from a Single-Institution Retrospective Analysis

by Ilario Giovanni Rapposelli, Serena De Matteis, Paola Lanuti, Martina Valgiusti, Giulia Bartolini, Paola Ulivi, Giorgia Marisi, Federica Pedica, Valentina Burgio, Giovanni Luca Frassineti, Stefano Cascinu, Andrea Casadei-Gardini
Published 2021-01-01